INTRODUCTION
Patients with chronic kidney failure (CKF) are at high risk of cardiovascular disease (CVD) 1 . Complex changes in both the cardiac and vascular systems result in structural and functional changes that can lead to reduced exercise tolerance, quality of life, increased morbidity and ultimately premature death 2 . CKF causes arterial stiffening resulting in reducing arterial cushioning of phasic pressure changes 3 . The resulting increase in left ventricular (LV) afterload combined with a host of metabolic stimuli including inflammation, oxidative stress, renin-angiotensin system activation, changes in phosphate metabolism and production of FGF-23 promotes an increase in LV mass and reduced myocardial perfusion 4 5-7 . The hemodynamic sequelae of such morphological alterations imply a high cardiac energy expenditure and elevated oxygen consumption in the myocardium.
The LV abnormalities in CKF reflect both myocyte hypertrophy and ultrastructural changes such as myocardial fibrosis 8 . These changes result in impaired myocardial relaxation and elevation of LV filling pressure 8, 9 . This impairment in diastolic function along with more subtle changes in systolic function leads to a high incidence of heart failure (HF) 3,6,10 with a reduction in exercise capacity 11 . Oxygen consumption at peak exercise (VO 2 peak) is a metric that provides an index of exercise capacity and represents the cardiovascular system's ability to take up, distribute and utilize oxygen at maximal exercise. Reduced values of VO 2 peak have been shown to predict prognosis in the HF population 12, 13 . Several studies have also demonstrated a reduced VO 2 peak in patients with CKF [14] [15] [16] and this was also associated with poor survival 14, 17 . The precise relationship between adverse structural alterations of the cardiovascular system and VO 2 peak in CKF patients is currently unknown.
In this study, we hypothesized that increased LV mass, filling pressure and arterial stiffness are associated with reduced VO 2 peak in patients with CKF. Using a control group of patients with treated essential hypertension but without CVD we also investigated the hypothesis that the main determinants of structural and functional cardiovascular changes and VO 2 peak in CKF are a result of mechanisms other than hypertension.
METHODS

Study Design and Clinical Data
Inclusion criteria were patients aged ≥18 who were either waitlisted or scheduled for kidney transplantation at our center, University Hospitals Coventry and Warwickshire NHS Trust, United Kingdom. In parallel, individuals with treated essential hypertension but without evidence of CVD (HF, ischemic heart disease, cerebrovascular disease), diabetes or secondary causes of hypertension were recruited at random from the community through primary care database. In both groups, patients with pre-existing chronic lung disease were excluded. All recruited patients underwent cardiopulmonary exercise testing (CPET), arterial applanation tonometry and a study-specified echocardiogram. For patients who were hemodialysis dependent, these assessments were carried out on the first non-dialysis day that was at least 12 hours after the last dialysis session in order to avoid the effects of Written informed consent was obtained from all eligible participants.
Cardiopulmonary Exercise Testing
The CPET was conducted using an electronically braked, upright cycle ergometer to maximal tolerance incorporating an individualized work rate. An experienced blinded investigator carried out all exercise testing. Before each test, the equipment was calibrated using standard reference gases and a 3-litre syringe. Care was taken to ensure each study patient understood the maximal exercise test protocol.
This included explanation of the anticipated early symptoms of lactic acid associated leg fatigue or discomfort that must not lead to premature cessation of pedaling or incremental loading. Each patient rested for 3 minutes followed by 3 minutes of unloaded pedaling prior to workload increments and continuous 12-lead ECG was recorded. Continuous breath-by-breath gas exchange analysis (VIASYS, MasterScreen CPX ® , Hoechberg, Germany) was performed. All patients were repeatedly encouraged to continue until symptom limited volitional fatigue.
The VO 2 at the point of anaerobic threshold (VO 2 AT) was determined by the Vslope method in conjunction with analyses of the ventilatory equivalents and end-tidal gas tension plots 20 . VO 2 peak was measured as the highest VO 2 achieved during the final 20-second averaging of peak exercise. 
Evaluation of Vascular Compliance
Pulse wave analysis was performed on the radial artery and aortic (carotidfemoral) pulse wave velocity (PWV) was determined by sequential recording of ECGgated carotid and femoral waveforms using the high fidelity micromanometer (SPC-301, Miller Instrument, Houston, Texas). As augmentation index is influenced by heart rate (HR), an index adjusted to a HR of 75 beats/minute (AIx 75 ) was recorded
22
. All measurements were derived using a validated radial-to-aortic transfer function (SphygmoCor, AtCor Medical Pty Ltd, Australia). An experienced operator, masked to the echocardiographic and CPET data, made all measurements in triplicate. Mean values of all tonometric measurements were used for analysis.
Statistical Methods
CKF patients were initially matched to the essential hypertension without CVD subjects in age, sex and body mass index (BMI) in a 1:1 ratio using a propensity score matching algorithm 23, 24 . To evaluate the potential adaptive functional cardiovascular changes that account for the difference in VO 2 peak between the two patient groups, variables that were statistically significant predictors of VO 2 peak in multiple regression models were additionally assessed by fitting models comprising the interaction term of patient group (binary variable) with the predictor variable of interest. The estimate of the interaction effect is denoted ∆B and may be interpreted as the difference of the slopes of the predictor between the groups. These models were adjusted for age, sex, BMI, hemoglobin, duration of hypertension and β-blocker usage. All hypothesis tests were two sided and a p-value <0.05 was considered to indicate statistical significance. SAS software, version 9.3 (SAS Institute Inc.) was used. (See Supplementary extended methods).
RESULTS
Clinical characteristics
Descriptive characteristics of all the study participants are presented in Table 1 .
CKF patients and subjects with essential hypertension without CVD were adequately matched in age ( 
Functional cardiovascular reserve in CKF versus essential hypertension
The metabolic measures of CPET for the two groups are shown in Table 3 . All patients performed exercise to a level accompanied by a respiratory exchange ratio (RER, ratio of CO 2 production to O 2 consumption) of >1.15. The mean of RER at the point of VO 2 AT for the study populations was 0.9±0.1. Relative to the essential hypertension subjects, the CKF patients had a significantly lower VO 2 peak (18.8 vs. 
Independent predictors of VO 2 peak
Univariate linear regression analyses for the two groups are presented in Table   4 . Differences between the CKF and essential hypertension populations in the unstandardized regression coefficients (b) and estimated regression lines for regressing VO 2 peak onto individual cardiovascular measures are highlighted by Figure 1 . Increasing LV mass index was positively associated with higher VO 2 peak in the essential hypertension subjects (b=0.21, p<0.001) but not in the CKF population (b=-0.01, p=0.9). Higher LVEDVI was associated with a significantly higher VO 2 peak in the hypertensives (b=0.41, p<0.001) but not in the CKF cohort (b=0.01, p=0.7).
Higher LV filling pressure (E/mean e') was significantly negatively associated with VO 2 peak in the CKF (b=-5.10, p<0.001) but not in the essential hypertension cohort (b=-1.37, p=0.7). LV ejection fraction had no association with VO 2 peak in either group.
Both AIx 75 and PWV had an inverse relationship with VO 2 peak in the CKF as well as the essential hypertension cohorts.
Cardiac structural variables and VO 2 peak in the multiple regression models
Results of multiple linear regression models for the CKF and essential hypertension without CVD populations are presented in Table 5 . In the CKF population (adjusted R 2 =0.45), higher E/mean e' was significantly associated with a lower VO 2 peak (b=-3.55, p=0.001) after adjusting for demographics, hemoglobin and duration of hypertension. In the essential hypertension cohort (adjusted R 2 =0.66), larger LVEDVI (b=0.21, p=0.002), LV mass index (b=0.10, p=0.01) and higher peak HR were significant predictors of higher VO 2 peak (b=0.12, p<0.001).
Associations between cardiac structural variables and VO 2 peak
The effects of the cardiac structural variables on VO 2 peak in the two groups
were compared in a model that included the group x predictor interaction terms, adjusting for demographics, hemoglobin and duration of hypertension. The regression slope for LV mass index predicting VO 2 peak was steeply more positive in the essential hypertension population compared to that of the CKF cohort (∆B=-0.17, 95% CI -0.24 --0.10, p<0.001) (Figure 2A) . The regression slope for LVEDVI and VO 2 peak in the essential hypertension subjects was also significantly more positive than the CKF population (∆B=-0.36, 95% CI -0.47 --0.24, p<0.001) ( Figure 2B ).
Association of arterial stiffness and VO 2 peak
PWV and AIx 75 were significant independent predictors of VO 2 peak in the CKF and the essential hypertension subjects (Figure 1E-F ; Table 4 ). Importantly, the interaction effect between patient group and both measures of arterial stiffness was not significantly different adjusting for demographics, hemoglobin and duration of hypertension ( Figure 2C-D) . Therefore, there is no evidence to suggest that the association of arterial stiffness with VO 2 peak differs between the groups.
Peak heart rate predicts VO 2 peak but this relationship is blunted in CKF HR at peak exercise and oxygen pulse were higher among the essential hypertension subjects than the CKF cohort ( Table 3) . HR at peak exercise was also a significant independent and adjusted predictor of VO 2 peak in the essential hypertension but not among the CKF patients. The lower peak HR observed in the CKF subjects could be related to a greater use of β-blocker (Table 1) . Therefore, the effect of peak HR and oxygen pulse on VO 2 peak were each directly compared between the groups in a model that included the group x peak HR or group x oxygen pulse interaction terms, adjusting for β-blocker, demographics, hemoglobin and duration of hypertension. The regression slope of peak HR was steeper in the essential hypertension cohort compared to that of the CKF group (∆B=-0.11, 95% CI -0.18 --0.03, p<0.01) ( Figure 3A) . A similar relationship of oxygen pulse with VO 2 peak was also demonstrated by a steeper regression slope in the essential hypertension cohort than the CKF group (∆B=-0.37, 95% CI -0.68 --0.06, p=0.02) ( Figure 3B ).
DISCUSSION
To our knowledge, this is the first prospective study to evaluate measures of . In this study, we demonstrated that incremental LV mass changes and end-diastolic volumes in the CKF subjects were not positively associated with increments in the VO 2 peak which contrasted significantly with the essential hypertension controls. Even though myocardial growth and remodeling may be dynamic adaptive processes that occur early in the course of kidney failure, sustained cardiac afterloads exacerbated by uremia in CKF patients could therefore lead progressively to maladaptive hypertrophy. A plausible mechanism for this finding is that ultra-structural changes within the myocardium such as capillary deficit, fibrillar collagen accumulation, fibrosis and calcification alter the compliance and contractility of the LV in patients with CKF to a greater extent than occurs in hypertension resulting in a reduced functional cardiovascular reserve 5, 29 While the LV ejection fraction in the CKF patients was significantly lower than that of hypertensive subjects, this was not predictive of VO 2 peak. This finding is unsurprising as epidemiological data have shown that up to 50% of patients with HF in the absence of significant coronary artery disease have preserved LV ejection fraction 30 . The underlying hemodynamic mechanism leading to exercise intolerance, dyspnea and thereby reduced VO 2 peak 31 in these patients is probably mediated at least in part by the increased diastolic LV stiffness 32, 33 . A recent experimental study has also indicated that in uremia, the Na We observed an inverse relationship between LV filling pressure and VO 2 peak in the CKF group which differed markedly from the essential hypertension controls.
However, the similar measure of LV filling pressure in the two cohorts ( Table 2 ) and the lack of association between LV filling pressure and VO 2 peak in the hypertensives suggest that additional mechanistic factors are responsible for the reduced functional cardiovascular reserve in CKF.
Indices of arterial stiffness were similar between the CKF and hypertensive cohorts ( Table 2) . PWV and AIx 75 were significant independent predictors of VO 2 peak (Table 4) 
Limitations
Exercise training has been shown to improve VO 2 peak 46 but data on muscle mass or strength were not collected in this study. Despite these, extensive evaluation of the ventricular-vascular function and dynamics were carried out resulting in novel and important information on how these cardiovascular alterations could adversely impact the VO 2 peak in CKF. Also, Painter et al. 47 had previously shown that muscle conditioning through supervised five-month exercise training and normalization of hematocrit improved but failed to normalize VO 2 peak in hemodialysis-dependent patients, indicating other physiological contributors to the reduced cardiovascular reserve in these patients.
In conclusion, our study shows that there are complex cardiovascular alterations in CKF that are associated with reduced functional cardiovascular reserve.
Our findings provide a pathophysiological background for appreciating the association between the maladaptive ventricular-vascular dynamics and reduced VO 2 peak in CKF.
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